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Abstract
The Effects of Recreational Marijuana Dispensaries on Local Opioid Mortality
Patrick Morrison, Advised by Professor Lewis Davis
This study examines how recreational marijuana dispensaries in Colorado affect
opioid mortality at the county level. Using a difference-in-difference model with county
and year fixed effects, I estimate the impact of recreational marijuana dispensary access
on fatal opioid overdoses. Additionally, I employ distance from a major roadway and
border as two instrumental variables to help limit the endogeneity associated with the
location of dispensaries. Previous studies have shown that medical and recreational
marijuana dispensary access decreases opioid mortality at the state level. Still, no study
has explored the connection between recreational marijuana dispensaries and overdoses
at the county level. Using data from the CDC, Colorado Department of Revenue, US
Census, and other sources, I found that under some specifications, one additional
dispensary is associated with a 0.0668 to 0.0747 unit decline in opioid mortality.
However, this result was not robust under every specification. Given the worsening
opioid crisis in the United States, research into alternate methods of reducing opioid
mortality is critical.

ii
Table of Contents
1. Abstract......................................................................................................................................i
2.

Introduction...............................................................................................................................1

3.

Background and Literature Review..........................................................................................3
A History or Marijuana Legalization..................................................................................4
Social Consequences of Legalization...................................................................................5
Medical Marijuana and Opioid Mortality...........................................................................8
Motivation............................................................................................................................9

4. Data..........................................................................................................................................11
5. Method.....................................................................................................................................14
6. Results......................................................................................................................................16
Instrumental Variable Regression......................................................................................18
7.

Conclusions.............................................................................................................................21

8. Works Cited.............................................................................................................................24
9. Appendix.................................................................................................................................26
Outputs 1-8.........................................................................................................................26
Histogram of Opioid Fatalities..........................................................................................32

Morrison 1

I.

Introduction
In recent years, the United States has been dealing with a public health crisis.1

Unintentional injuries, including drug overdoses, are the leading cause of death among
Americans under forty-five years old.2 Overdoses alone account for more deaths than any other
single cause.3 From April 2020 to April 2021, more than 100,000 Americans died from drug
overdoses, a 28.5% increase from the prior year.4 Efforts to curb the opioid crisis, including
rehabilitation clinics, support groups, and methadone clinics, have not solved the problem. Over
the last several years, the crisis has been exacerbated by the rising prevalence of heroin and
synthetic opioids like fentanyl, which are less expensive and more potent. Because heroin and
fentanyl are cheaper than prescription painkillers, the demand for opioids has increased.
Policymakers, and suffering citizens, have looked to alternate methods of reducing the harm
caused by opioids in both their prescription and synthetic forms. Although evidence is mixed,
some previous studies have shown that medical marijuana can substitute for opioids and
consequently reduce the number of opioid overdoses. However, far less work has been done
linking recreational marijuana and opioid abuse. As the opioid crisis moves further away from
prescription painkillers and progresses toward more dangerous synthetic opioids, such as heroin
and fentanyl, the effect of recreational marijuana on opioid overdoses becomes an important
policy question.
This study will examine the effect of recreational marijuana dispensaries on opioid
overdoses at the county level in Colorado. This study uses a difference-in-difference
specification with data from the CDC Multiple Cause of Deaths files, the US Census Bureau, the
1

No, not that public health crisis.
Overdoses are not necessarily fatal. However, for simplicity, this paper will only use ‘overdoses’ to refer to ‘fatal
overdoses.’
3
https://www.cdc.gov/injury/wisqars/animated-leading-causes.html
4
https://www.washingtonpost.com/health/2021/11/17/overdose-deaths-pandemic-fentanyl/
2
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Colorado Department of Revenue, and the Bureau of Labor Statistics. In the
difference-in-difference specification, this study found that opening an additional dispensary is
associated with a -0.0668 unit decrease in overdoses. This finding implies that opening an
additional fifteen dispensaries would lower the number of overdoses in a county by one. This
result was not robust to every specification. CDC data suppression standards lowered the number
of observations from 704 to 97, substantially increasing the standard errors and biasing the
coefficients toward higher values.
The OLS estimation may suffer from endogeneity, so we utilized an instrumental variable
specification using distance from a major roadway and border as instruments. Endogeneity may
be an issue because the location of recreational marijuana dispensaries is not random, and it is
reasonable to assume that areas with a high demand for recreational marijuana may also have a
high demand for opioids. In the instrumental variable regression, this study found that opening
an additional dispensary is associated with a -0.0747 unit decrease in overdoses, implying that
opening approximately thirteen additional dispensaries would lower the number of overdoses by
one. Again, this result was not uniformly robust across specifications and suffered from a limited
number of observations. We can observe that the difference-in-difference and instrumental
variable regression results are similar, suggesting that endogeneity bias may not be as severe as
feared. In any case, these similar results help affirm the veracity of this finding.
To my knowledge, this study is the first to consider the effects of recreational marijuana
dispensaries on opioid mortality at the county level. Colorado was the first state to open
recreational marijuana dispensaries in 2014, making them an ideal case study for this analysis.
This study will focus on the time frame 2009-2019 to allow for a relatively even number of years
before and after legalization while avoiding the endogenous effects of the COVID-19 pandemic

Morrison 3
on opioid overdoses. As many states weigh the benefits and consequences of legalization,
relevant policy research into the effects of marijuana legalization on other aspects of society is
crucial. Recreational marijuana is available to a larger segment of the population than medical
marijuana, suggesting that it could interact with opioid use in unforeseen ways. Medical
marijuana is a good substitute for prescription painkillers, but as the opioid crisis shifts toward
synthetic drugs like heroin and fentanyl, we must consider whether recreational marijuana serves
as a better substitute for these deadlier alternatives.
The paper will proceed as follows. Section II will discuss the background and literature
review, building the theoretical framework for this analysis. Section III will discuss the data
sources and manipulations used to generate the variables. Section IV will describe the model in
detail, explaining the logic behind the difference-in-difference specification and the instrumental
variable regression. Section V will feature the results and discuss their meaning in relation to the
existing literature and implications for future policy. Finally, section VI will conclude the
analysis with a summary of the findings and potential avenues for future research.

II.

Background and Literature Review
The opioid crisis has received prominent attention in the media and has touched the lives

of many families in the United States. The root causes of opioid addiction have a sinister history
in the United States. Prescription painkillers such as OxyContin prescribed for unverifiable
maladies like chronic pain made up the majority of overdoses until 2010 (Anderson, Rees 2021).
That year, the makers of OxyContin reformulated the pill to make it harder to abuse. Over the
following decade, the opioid crisis shifted toward heroin and fentanyl, helping cause the recent
surge of overdoses (Evans et al., 2018). Economic conditions can also affect drug abuse. Ruhm
(2018) describes this framework, defining “deaths of despair” as excess deaths caused by drug
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overdose, suicide, or alcohol-related injury. However, Ruhm found that medium-run economic
conditions cause only one-tenth of these deaths of despair and that counties with more severe
economic decline had relatively more deaths of despair.
Meanwhile, recreational and medical marijuana dispensaries have proliferated in recent
years, with thirty-six states allowing medical marijuana and eighteen states allowing recreational
marijuana.5 In particular, recreational marijuana is a new phenomenon, with Washington and
Colorado being the first to legalize it in 2012. Recreational marijuana legalization marks a
dramatic change in US drug policy, affecting a significant portion of the nation’s population. As
a national debate over the costs and benefits of marijuana legalization continues, a natural
question is, how will recreational marijuana legalization affect the opioid crisis? If a significant
relationship exists between these two drugs, policy decisions concerning either should consider
this connection. Particularly, if recreational marijuana and opioids are substitutes, the opening of
new recreational marijuana dispensaries could significantly decrease local opioid mortality.
A History of Marijuana Legalization
We will start with a brief history of medical and recreational marijuana legalization.
Although some states had banned the use of marijuana in the early twentieth century, the Federal
government effectively banned its medical and recreational use nationally in 1937 with the
Marijuana Tax Act. In 1970, the Controlled Substances Act classified marijuana as a Schedule I
drug, indicating no known medical use and a high potential for abuse. The war on drugs
developed in the following decades, increasing violent crime, property crime, and the prison
population (Miron 2004). In 1996, California passed Proposition 215, allowing for the medicinal
use of marijuana and legalizing the drug’s possession, cultivation, and retail sale to qualified
patients. In 2009, the Deputy Attorney General released the Ogden Memo, stating that the
5

Washington D.C. has also legalized recreational and medical marijuana.
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federal government would not actively prosecute medical marijuana users in compliance with
their respective state laws. Over the following years, several states legalized medical marijuana
in response, and today, thirty-six states and Washington D.C. have legalized medical marijuana.
Washington and Colorado passed the first recreational marijuana laws in 2012. The 2013
Cole Memorandum clarified the federal government’s plan for enforcing state marijuana
legislation and specified instances where they would intervene. Oregon and Alaska legalized
recreational marijuana in 2014, while Colorado and Washington began commercial sales. Today,
eighteen states and D.C. have legalized recreational marijuana, with eleven states operating retail
dispensaries. The Cole Memorandum was repealed in 2018, and the House of Representatives
recently passed the MORE Act in 2020, a substantive step toward federal legalization.
Social Consequences of Legalization
There is fear that marijuana legalization will come with unintended social consequences.
This section will address a few leading areas of concern: legalization’s impact on crime, teen
consumption, alcohol consumption, and painkiller prescriptions. Anti-marijuana arguments hinge
on the premise that marijuana is a complement for other drugs so that an increase in marijuana
consumption would increase other drug use. However, the evidence suggests that marijuana may
be a substitute for other drugs and that its effects on teen consumption are minimal. This finding
suggests that the primary arguments against legalization are flawed, and indeed, legalization may
present more social benefits than costs.
One of the primary arguments against legalized marijuana is the concern that drug usage
leads to more non-drug crimes. If marijuana and opioids are complementary goods, we would
expect recreational marijuana dispensary openings to increase crime. Brinkman and
Mok-Lamme (2017) examined the effect of retail dispensary concentration on neighborhood
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crime in Denver and found that legalization led to a highly localized crime reduction, with few
effects on surrounding neighborhoods. They utilized a difference-in-difference approach and
instrumented the distance to a major roadway to observe changes in crime that resulted from
changes in dispensary accessibility. Overall, they found that opening a new dispensary is
associated with a reduction of 17 crimes per 10,000 residents. In a similar study, Burkhardt and
Goemens (2019) used a difference-in-difference specification to examine the effects of
dispensary openings on a wide range of crimes and found a reduction of crimes within a
half-mile of new dispensaries, but only in above-median income neighborhoods. Further, they
found a 13% reduction in hard drug and alcohol-related crimes but a 15% increase in car
break-ins.
Finally, Dragone et al. (2018) used difference-in-difference and spatial discontinuity
designs to examine the quasi-experimental changes in recreational marijuana laws along the
Washington-Oregon border. Following legalization, Washington saw a 2.5% increase in
marijuana consumption and a 0.5% decrease for other drugs. There was a statistically significant
reduction in rapes and property crimes, with the authors concluding that legal marijuana does not
increase crime and possibly reduces it. One benefit of dispensaries is that marijuana users can
avoid utilizing the black market. Interactions with drug dealers provide access to harder drugs
than dispensaries would, and black market interactions are more likely to result in drug
tampering, violence, or robbery. Together, these findings support the notion that marijuana is a
substitute for alcohol and harder drugs that are more likely to be associated with criminal
behavior.
Aside from crime, a sizable literature exists discussing whether marijuana is a
complement or substitute for other substances. The “gateway drug” hypothesis suggests that
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marijuana use leads to other alcohol and drug experimentation, ultimately increasing the
likelihood of addiction and overdose. Early work focused on the connection between the legal
drinking age and marijuana use. Yoruk and Yoruk (2011) found that marijuana use drastically
increased at twenty-one years old (suggesting complementarity), whereas Crost and Guerrero
(2012) found a sharp decrease in use (suggesting substitutability). In a reply to the Journal of
Health Economics, Crost and Rees (2012) replicated Yoruk and Yoruk’s results and found that
they inadvertently conditioned on having used marijuana in the past month. After correcting this
error, Crost and Rees confirmed that marijuana use decreases at twenty-one years old. Similarly,
Anderson et al. (2013) showed an 8-11% decrease in traffic fatalities in the first year after
medical marijuana legalization via a reduction in alcohol consumption. This result does not
imply that driving under the influence of marijuana is safe but instead suggests that alcohol and
marijuana are substitutes.
There is a valid concern that legalizing marijuana signals to teenagers that use is not risky
and subsequently increases youth consumption. Using data from the Youth Risk Behavior Survey
and exploiting geographic and temporal variation, Anderson et al. (2015) showed no causal
relationship between legalization and teen use. They argue that the introduction of legal
dispensaries crowds out drug dealers and decreases the supply of marijuana to teenagers. The
paper found a 1.5% increase in teen use associated with legalization, but this change could be
due to changing attitudes regarding the risks of marijuana use. There is no study connecting teen
marijuana use and future opioid abuse, so the best evidence of their substitutability comes from
the medical marijuana literature.
Understanding how medical marijuana affects opioid consumption is best seen in
research regarding medical marijuana and prescription medication use. Both marijuana and
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opioids are used to treat chronic pain, so we expect medical marijuana dispensary openings to
decrease opioid prescriptions. Bradford and Bradford (2018) examined the relationship between
legalization and prescriptions that marijuana is known to also treat under Medicare Part D. Using
a difference-in-difference specification on a near-census of Medicare Part D prescriptions from
2010-2015, they found that access to a medical marijuana dispensary results in 2343.9 fewer
daily doses of prescription pain medication per year. This result suggests that marijuana and
prescription painkillers are substitutes for chronic pain sufferers.
Directing chronic pain sufferers away from prescription painkillers and toward legal
marijuana has high potential benefits. Many states have adopted prescription drug monitoring
programs (PDMPs) to regulate the activities of “pill mills,” chronic pain clinics that gained
notoriety for overprescribing painkillers, often for personal monetary gain. Chronic pain poses
issues because it is a debilitating condition to live with and difficult to verify that a given person
is suffering from it. Marijuana can treat chronic pain without the negative consequences of
opioid addiction, making legalization a viable alternative. There is reason to believe that
recreational marijuana works similarly to medicinal marijuana, and a larger segment of the
population who have not sought chronic pain relief or have been illegally self-medicating will
have access to a legal alternative.
Medical Marijuana and Opioid Mortality
A notable literature exists connecting the introduction of medical marijuana laws and
opioid mortality in the United States. One critical early study was Bachhuber et al. (2014) which
found that states with medical marijuana laws saw a 24.8% relative decrease in non-suicide
opioid deaths. Further analysis indicated that the relationship between medical marijuana and
lowered overdoses strengthened over time. This result was widely reported in the media and is
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frequently cited by pro-marijuana advocates and politicians (Anderson, Rees 2021). Recently, an
analysis by Shover et al. (2019) found that when replicating the result with data through 2017,
the sign flipped significantly, indicating that medical marijuana states now experience greater
than expected opioid overdoses. They argue that pro-marijuana advocates are using Bachhuber et
al.’s finding as proof that marijuana and opioids are substitutes and that, in general, the negative
association is not robust. These conflicting findings serve as part of the motivation for the current
study, as the relationship between marijuana use and opioid overdoses has come into question.
Helping to confirm Bachhuber’s original finding, Powell et al. (2018) found that
heterogeneity in medical marijuana laws affected their relationship with prescription opioid
abuse. Using data from Medicare Part D, they found that marijuana access lessened opioid abuse
and that laws allowing for greater access to operational dispensaries saw the largest effect. They
used a difference-in-difference approach with non-medical states as the control group and
exploited differential timing of implementation. Building on the idea that access to operational
dispensaries drives the effect of medical marijuana on overdoses, Smith (2020) examined
dispensary openings at the local level using a difference-in-difference approach. He found an
11% decrease in opioid-related fatalities following a dispensary opening and a 17% reduction in
counties after the first three years of operation. These results corroborate the previous findings
and help argue that marijuana acts as a substitute for opioid abuse.
Motivation
Given the evidence of medical marijuana’s substitutability for alcohol and prescription
opioids, without a notable increase in teen use, it follows that recreational marijuana would have
a similar effect. The key difference between medical and recreational marijuana is that a far
broader group of people can use recreational marijuana. This study examines whether access to
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recreational marijuana, primarily through dispensaries, affects local opioid overdoses. Counties
with more functioning dispensaries should see a relative decline in overdoses compared to
counties in the same state with fewer dispensaries. If marijuana’s substitution effect extends to
more potent opioids like heroin and fentanyl, we expect to see a relative decrease in overdoses in
states that have legalized recreational marijuana.
The recent shift toward synthetic opioids undermines the ability of medical marijuana to
combat the opioid crisis. Shover et al.’s (2019) work shows that relying on medical marijuana
research fails to account for recent changes in the opioid crisis. As the nature of the crisis
changes, medical and recreational marijuana may prove less closely related, prompting a need to
study recreational marijuana’s effect alone. If medical marijuana is no longer effective,
understanding the effects of recreational marijuana becomes increasingly important, as the two
forms of legalization may have a different effect on opioid overdoses.
The most comparable work to this study comes from Chan et al. (2020). They used a
difference-in-difference approach to estimate the effects of medical and recreational marijuana
laws on opioid mortality rates, finding that these laws reduce overdoses by 20-35%. This paper
was one of the first analyses of the effect of recreational marijuana laws on opioid overdoses.
Notably, they found that recreational marijuana had a greater effect on synthetic opioids. Their
findings are particularly important given the recent shift toward these more potent and lethal
alternatives. This analysis occurs at the state level and includes data from the CDC National Vital
Statistics System from 1999-2017, when eight states had an operational recreational marijuana
dispensary for any amount of time. Their findings support the notion that recreational marijuana
legalization has different effects depending on the nature of the opioid crisis.
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The present study will consider a similar research question to Chan et al. (2020), with
some key differences. First, this study will examine the effects of recreational marijuana
dispensary openings at the county, rather than state, level to determine the impact of new
dispensary openings on opioid mortality in the surrounding area. To my knowledge, no study
examines this issue at the county level. These findings will help inform local policymakers in
states where recreational marijuana dispensaries are legal to decide if opening a dispensary in
their community is advisable. Further, we will benefit from a longer sample period than other
studies. Most prior studies have used medical marijuana as a proxy for recreational marijuana,
but given the changing nature of the opioid epidemic, observing recreational marijuana’s effects
directly is crucial. If recreational marijuana is a better substitute for heroin and fentanyl than
medical marijuana, understanding this relationship could help end the opioid crisis.

III.

Data
The data for this study derives from multiple sources. It covers an eleven-year span from

2009-2019. This time frame offers an equal number of years before and after legalization (in
2014) while avoiding the effects of Covid-19 on opioid overdoses. Colorado overdose mortality
data comes from the CDC Multiple Cause of Death files (MCOD) 2009-2019. The MCOD
dataset includes county-level mortality data for the United States, compiled from death
certificates. Overdose deaths are coded following CDC standards, with X40-44, X60-64, X85,
and Y10-14 indicating unintentional overdoses, suicides, homicide, and undetermined,
respectively. These data represent virtually all opioid-related deaths in Colorado during the
sample period. Unfortunately, confidentiality standards suppressed a significant portion of the
overdose data in low-population counties. In total, we have only 97 county-year observations
from eleven different counties. The ‘opioid_ods’ variable provides the total number of opioid

Morrison 12
deaths during that county and year and serves as the dependent variable of interest. The natural
log of ‘opioid_ods’ will serve as an additional dependent variable, encoded as ‘log_deaths.’
Data on recreational marijuana dispensary locations in Colorado was constructed from
the Colorado Department of Revenue (CDR).6 The CDR’s Marijuana Enforcement Division
maintains archived records of licensed facilities, so I assigned opening year values to each
dispensary. To calculate the total number of dispensaries in each year by county, I summed the
number of dispensaries open in each year from 2014-2019. For each county-year observation
from 2009-2013, the number of dispensaries is zero because Colorado’s first recreational
marijuana dispensaries opened on January 1, 2014. Finally, I collapsed dispensaries by county
and reshaped the data into panel format to merge later. This process was used to create the ‘disp’
variable, the key independent variable.
County-level demographic data was compiled from the United States Census Bureau
from 2010-2019. These data include population information for median age, race, ethnicity, and
sex. Values for 2009 were not available, so I generated predicted values by calculating and
inverting the growth rate during 2010 and 2011. The ‘tot_pop’ variable represents the county’s
total population in that year and will control for county size as a determinant of overdoses. The
effect of age is controlled for by ‘median_age.’ I generated the variable ‘male_pct,’ which
represents the percentage of the total population that is male, calculated as the total number of
men in a county divided by its population. I generated ‘minority_pct’ as the share of all Hispanic
or Black men and women in a county divided by the total population. Poverty rate data comes
from the US Census Small Area Income and Poverty Estimates (SAIPE) program. This data will
help create an interaction term to determine differential effects of socioeconomic characteristics
across counties. Unemployment rate data comes from the Bureau of Labor Statistics and
6

Available at: https://sbg.colorado.gov/med/licensed-facilities
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provides a county-level measure of economic conditions, helping control for the effect of
medium-run economic downturns.7 The data came as several Excel files that I combined and
copied into Stata.
The instrumental variables are the distance from a major roadway (‘road_dist’), and the
distance from a border (‘border_dist’) come from the US Census TIGER database and was
provided courtesy of Jeffrey Brinkman at the Federal Reserve Bank of Philadelphia.8 I averaged
the distance to a major roadway by county and repeated this process for border distance. The
‘road_dist’ variable thus represents the average distance of a dispensary to a major roadway by
county. Similarly, ‘border_dist’ represents the average distance of a dispensary to a border by
county. These variables were then merged into the master dataset. The following section will
discuss the validity of these instruments and their role in this analysis. See the following table for
summary statistics of these variables.
Table 1: Summary Statistics

7

Variable

Observations Mean

Std. Dev.

Min

Max

opioid_ods

97

27.94845

13.99358

10

81

disp

704

3.666193

14.8235

0

170

road_dist

704

170109.3

99150.64

1728.691

377139.2

border_dist

704

4036.982

3590.253

62.44915

22428.86

unemployment

704

5.476989

2.909329

1.5

18.5

tot_pop

704

83816.74

168584.9

689

727211

male_pct

704

.5188131

.0371982

.4791356

.7348622

minority_pct

704

0.2041936

0.1435578

0.0124761

0.6703632

median_age

704

41.89077

5.744856

31.2

57.2

This data is easily accessible at https://www.bls.gov/lau/#tables
See the paper: Brinkman, Jeffrey, and David Mok-Lamme. “Not in my backyard? Not so fast. The effect of
marijuana legalization on neighborhood crime.” Regional Science and Urban Economics Vol. 78 (2019): 103460.
8
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IV.

Method
This study uses a difference-in-difference specification. This equation summarizes the

underlying logic of a difference-in-difference model:

Difference = ΔYT - ΔY C

(1)

ΔYT represents the change in treated counties. In this study, the treatment is the presence of
recreational marijuana dispensaries, with ‘disp_dum’ representing the presence of any
dispensaries and ‘disp’ giving the discrete count of dispensaries. ΔYC represents the change in
counties without dispensaries or with relatively fewer dispensaries. The difference between the
two terms in (1) represents a naive estimate of the policy’s effect.
To control for other changes, I examine the causal effect of local dispensary openings on
opioid mortality using the following equations:
Deathsit = ꞵ0 + ꞵ1Dispit + ꞵ2Interactionit + ꞵ3Unemploymentit + ꞵ4X + 𝜖it

(2)

Deathsit = ꞵ0 + ꞵ1Disp_dumit + ꞵ2Interactionit + ꞵ3Unemploymentit + ꞵ4X + 𝜖it

(3)

Where Y it is the dependent variable, indicating the difference in opioid overdoses. ꞵ1Disp
represents the number of dispensaries in a county and ꞵ1Disp_dum represents if the county has
any dispensaries. ꞵ2Demographicsit represents the county-level demographics to control for
differences in sex, race, ethnicity, and age. ꞵ3Unemploymentt controls for the county-level
unemployment rate, a proxy for general economic conditions. ꞵ4X represents a vector of control
variables and 𝜖it is the error term, which encapsulates all unobserved variables that affect the
dependent variable. The subscripts ‘i’ and ‘t’ indicate county and year fixed effects.
Where dispensaries choose to open is not random and there is concern that this will
introduce endogeneity into the OLS estimation. We expect the endogeneity to be positive
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because dispensaries are more likely to open in urban areas where there is high demand for
recreational marijuana. We suspect that these attributes that partly determine dispensary location
affect opioid mortality, so to combat the problem of endogeneity, I will utilize two instrumental
variables following the standard two-stage least squares method. The instruments of choice are
the distance between a recreational marijuana dispensary and a major roadway and border. I
argue that this instrument satisfies both the inclusion and exclusion criteria. It follows that there
will be increased demand for recreational marijuana in more accessible locations, making it a
significant determinant of total dispensaries. This intuition can be tested empirically in a reduced
form regression, as in Equation 4. This test occurs under Output 6 (see Appendix) in the next
section.
The first-stage equation is:
Disp = ɣ0 + ɣ1Roadway + ɣ2Border +ɣ3X + ν

(4)

‘Disp’ is the independent variable of interest in our first-stage equation. ɣ1Roadway and ɣ2Border
are the exogenous effects of our instrumental variables on the number of dispensaries in a
county. ɣ3X represents the other control variables, and ν is the error term. The first stage isolates
the effect of ‘Disp’ that does not arise from correlation to the error term.
The second-stage equation takes the fitted-value 𝐷𝑖𝑠𝑝 as in independent variable, as
below:
Deaths = ꞵ0 + ꞵ1𝐷𝑖𝑠𝑝 + ꞵ2X + 𝜖

(5)

Y in equation (5) represents our outcome of interest, opioid overdoses. ꞵ 1𝐷𝑖𝑠𝑝 is the coefficient
of our fitted-value, and ꞵ2X represents the vector of control variables described above. Because
𝐷𝑖𝑠𝑝 is a fitted-value, its inclusion will increase the standard error in (5). Testing the correlation
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between roadway and border distance and the number of dispensaries helps determine the
instrument’s strength.
Data suppression issues removed many of the observations that we would like for this
analysis. In an attempt to glean some value from this missing data, we will demonstrate the effect
of ‘disp’ and ‘disp_dum’ on the binary dependent variable ‘suppressed.’ The regression takes the
form:
Suppressed = ꞵ0 + ꞵ1Disp + ꞵ2X + 𝜖

(6)

Suppressed = ꞵ0 + ꞵ1Disp_dum + ꞵ2X + 𝜖

(7)

Where ‘Suppressed’ equals one if the data is suppressed (fewer than ten observations) and zero
otherwise. As before, ‘Disp’ and ‘Disp_dum’ represent the number of dispensaries and if there
are any, respectively. ‘X’ represents a vector of control variables and 𝜖 is the error term.

V.

Results
First, we begin with a demonstration of the effect of a dispensary on data suppression.

Mortality data are suppressed when there are fewer than ten observations in a county in a given
year. It follows that if counties with more dispensaries are more likely to have suppressed data,
then dispensaries reduce opioid mortality, even if we cannot directly observe the number of
overdoses. As Output 1 shows, a basic regression with the binary dependent variable
‘suppressed’ yields significant and positive results for both the ‘disp_dum’and ‘disp’ variables. 9
‘Disp_dum’ has a coefficient of 0.154, meaning that having any dispensaries is associated with a
15.4% increase in the likelihood of data suppression. ‘Disp’ has a coefficient of 0.00857,
meaning that every additional dispensary is associated with a 0.857% increase in the likelihood
of data suppression. Both of these results are statistically significant at the 1% level. This finding
9

Remember that ‘disp_dum’ represents if a county has any dispensaries, while ‘disp’ is a discrete number of
dispensaries.
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implies that counties with more (or any) dispensaries are more likely to have less than ten opioid
overdoses than counties with no dispensaries.
Next, we will use a difference-in-difference specification to estimate the impact of
dispensaries on opioid overdoses using county and year fixed effects. Due to data suppression,
we are limited to 97 observations in eleven different counties. The key independent variable is
the number of dispensaries, and Output 2 shows the results. We can see that using the natural log
of deaths as the dependent variable yields an insignificant result with a negative but small
coefficient. However, using the total number of deaths as the dependent variable yielded
significant results at the 5% level. The coefficient is -0.0668, implying that the opening of
approximately fifteen dispensaries is associated with a one-unit decrease in deaths. For an area
like Denver county, which has 170 dispensaries, this equates to a reduction of approximately
eleven deaths. Further, CDC suppression rules bias our coefficient toward a higher value because
counties with fewer fatalities are not included in our sample size. Thus, the actual effect has the
potential to be much larger.
Output 3 shows the results for a difference-in-difference specification using ‘disp_dum’
as the key independent variable, which signifies whether a county has any dispensaries. Column
(1) is insignificant and provides no insight into the effect of having any dispensaries on opioid
mortality. Similarly, column (2) shows that dispensaries insignificantly affect deaths. Because
both of these results are insignificant, we cannot conclude that having any dispensaries affects
opioid mortality. As before, these results are biased toward a greater coefficient due to
suppression standards removing the smallest values. We should also consider that dispensaries
tend to open in counties with higher populations (due to increased demand) and that high
population counties tend to have higher opioid mortality rates regardless of dispensaries.
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Dispensaries may have varying impacts on counties with different socioeconomic
characteristics. To examine this, I augment Outputs 2 and 3 by adding interaction terms for the
poverty rate and percentage of the population that is either Black or Hispanic. Output 4 shows
the results with ‘disp’ as the key independent variable. Columns (1) and (2) show that neither the
‘disp’ term nor either interaction term are significant under this specification. No conclusions
can be drawn from these regressions, given the low significance level. In both columns, the
minority percentage of the population is significant at the 5% level. However, the minority share
of the population interaction term is not significant. Output 5 shows the results with ‘disp_dum’
as the key independent variable, including interaction terms. As in Output 4, neither column (1)
nor column (2) shows a statistically significant effect. Since these results are insignificant, we
cannot draw any conclusions from this finding. As in Output 4, the interaction terms are all
insignificant, and only the minority share of the population is positive and statistically
significant.
Instrumental Variable Regression
Next, we will examine the results for our second-stage instrumental variable regression.
The OLS results in this study may be biased because the key independent variable, dispensaries,
are not randomly assigned to counties. Instead, counties choose where to open dispensaries for
several reasons, including demand, ease of access, and local laws. It is plausible that determining
where dispensaries are located correlates with the number of opioid overdoses in that area. Thus,
we employ two instrumental variables to mitigate the potential problem of endogeneity, distance
from a major roadway and distance from a border. This choice of instruments aligns with
Brinkman and Mok-Lamme (2017), who provided border and roadway data for the present
analysis. These instruments make sense because dispensaries are likely to open in areas easily
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accessible to customers, and being near a major roadway ensures that. Customers who do not
live in Colorado but want to consume recreational marijuana can access it by crossing the border,
implying that opening dispensaries near a border would increase demand. Instrumental validity is
conditional on satisfying the exclusion and inclusion criteria. The exclusion criteria cannot be
tested empirically, so we justify these instruments by considering that opioid overdoses should
have no intrinsic connection to the location of borders or roadways. The ubiquity of opioids
means that it is generally unnecessary for a typical user to purchase these drugs out of their local
area.
We will empirically test the inclusion criteria by regressing ‘road_dist’ and ‘border_dist’
on ‘disp.’ Output 6 shows the result. Both have negative coefficients and are significant at the
1% level. Output 7 shows the results for ‘disp_dum’ as the key independent variable
instrumenting on distance from a major roadway and distance from a border. When either
‘log_deaths’ or ‘opioid_ods’ are the dependent variable, we see a statistically insignificant effect,
though they would be significant at the 10% level. Both coefficients are large and negative, but
since they are not statistically significant, we cannot conclude anything from them. Output 8
shows the results when ‘disp’ is the key independent variable. Column (1) shows the results for
the natural log of deaths and again is not statistically significant. Column (2) suggests that
opening an additional dispensary is associated with a -0.0747 unit decrease in the number of
opioid fatalities. This result is significant at the 5% level. This finding implies that the addition
of approximately thirteen dispensaries would result in one fewer opioid overdose. This model
also produces an R-squared of 0.792, the highest of any specification in this study.
This concludes the explanation of the results, and this section will now discuss the
meaning of these findings. First, we should note that these results are not significant across all
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specifications, and thus we cannot affirm their robustness. Nevertheless, some specifications are
particularly interesting as they suggest that recreational marijuana dispensaries have a
non-negligible impact on opioid mortality. In particular, Output 1 shows that having dispensaries
(and higher numbers of dispensaries) increases the likelihood of data suppression. Since data are
only suppressed when there are fewer than ten fatalities, this finding implies that dispensaries
decrease the number of deaths. Data suppression reduced the number of observations from 704
to 97. This reduction greatly increased the standard error in the regressions, lessening their
ability to produce statistically significant results. It is encouraging that some specifications still
produced significant results despite this small sample size.
The preferred specifications are Output 2 column (2) and Output 8 column (2). These are
the number of dispensaries on the number of deaths and an instrumental variable regression
which calculates a fitted value for the ‘disp’ variable. The preferred specifications are both
statistically significant at the 5% level. In finding that specifications using the number of
dispensaries (‘disp’) as the explanatory variable, we can infer that the intensity of treatment is
more important than having the treatment at all. In other words, simply opening a dispensary is
not enough to create substantive change; there must be a sufficient number of dispensaries for
positive effects. If we focus on the preferred specifications, Output 2 allows us to conclude that
opening an additional dispensary is associated with a -0.0668 reduction in opioid fatalities, while
Output 8 suggests a -0.0747 reduction. Despite different estimation techniques, these estimates
are relatively similar, suggesting that they may be close to the true relationship. A
back-of-the-envelope calculation suggests that the opening of approximately 13-15 additional
dispensaries would save one life.
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VI.

Conclusion
This study examines the effects of recreational marijuana dispensaries on opioid

overdoses in Colorado. Using county-level mortality data from the CDC, demographic data from
the US Census, roadway and border data from the TIGER database, and unemployment data
from the Bureau of Labor Statistics, I find that, under some specifications, increases in the
number of dispensaries are associated with a decrease in opioid mortality by about -0.0668 to
-0.0747 per dispensary. This result is not robust to every specification, but given the limited
amount of data available, it points to a meaningful relationship between access to marijuana and
reduced opioid mortality. Unexpected data suppression reduced the total number of observations
from 704 to 97 while also biasing the results toward higher values, implying that there could be a
large and negative relationship between recreational marijuana dispensaries and opioid
overdoses.
Previous studies have linked recreational marijuana availability to reduced opioid
mortality at the state level, but to my knowledge, this is the first study to consider the effects at
the county level. Future research could improve this study in a few regards. First, gaining access
to the restricted use data would free up several hundred observations and massively reduce the
standard error in these regressions while eliminating the bias of results toward higher values.
Further, one original goal of this study was to isolate the effect of recreational marijuana on
synthetic opioids in particular, in line with the state-level findings of Chan et al. (2020).
However, the data suppression made this impossible, as removing any more observations would
make finding significant results infeasible. I believe that recreational marijuana may have a
particular effect on synthetic opioid use because users of medical marijuana tend to get
prescriptions for ailments that prescription opioids are also used to treat, such as chronic pain.
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Recreational marijuana is available to the general public and could be a better substitute for
synthetic opioids than medical marijuana.
Most studies to date have failed to support the ‘gateway drug’ hypothesis, which posits
that marijuana use leads to experimentation with ‘harder’ drugs. This study further weakens this
argument. In reality, both empirical studies and simple observations have shown that there are
not serious consequences to medical or recreational marijuana legalization. Marijuana is not
harmful when used responsibly and in moderation, and demand will be present regardless of
prohibition. Thus, legalization is the better policy, in no small part because removing marijuana
sales from the black market makes it difficult for sellers to offer dangerous alternatives, such as
opioids. The notable precedent of alcohol prohibition should make the issue of recreational
marijuana legalization common sense. In a similar vein, policy should consider broader
alternatives to prohibition to combat the worsening opioid crisis. Harm-reducing drug policies
can potentially shift the national response away from treating opioid addiction as a criminal
matter and instead address the public health issue that it is. Local recreational marijuana
legalization could act as another harm reducing measure that both refocuses policing efforts from
marijuana enforcement and decreases the number of opioid overdoses.
This study’s hypothesis that recreational marijuana dispensaries decrease county-level
opioid mortality is demonstrated in the preferred specifications, but this finding is not robust to
all specifications. No regressions using the natural log of deaths as the dependent variable yield
significant results under any specification. This is surprising given that the histogram of opioid
overdoses (see Appendix) appears to support logging this variable. Colorado was the first state to
open recreational marijuana dispensaries, but several states have followed suit in recent years.
Early results do not indicate major adverse effects associated with this shift in policy. As more

Morrison 23
data becomes available, better econometric analyses of the effects of legalization will help
cement the relationship between marijuana and opioids, crime, labor, and a host of other
outcomes.
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